WASHINGTON — Federal health officials announced a pilot program Monday to speed up early-stage clinical trials, which they ...

An NIH grant proposal poses new threats, more cases of a livestock disease in Europe, and more health news from Morning ...

Health disparities researchers say a new White House proposal could disqualify much of their work from federal funding — ...

Sanofi said that Paulo Fontoura, the chief medical officer at Xaira, would be taking over as its head of R&D, as the company ...

They’ve blown past last year’s totals in roughly half the amount of time. Pharma companies struck 26 blockbuster M&A deals in ...

The psychiatric ER is “a detox center for those with no safe place to withdraw and a respite center for caregivers at their ...

Nearly 30% of the data collected in clinical trials do not directly inform key decisions, yet patients are still asked to ...

The sudden turnaround is the latest in a series of apparent FDA reversals in the past two months, after leaders installed by ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. The Food and Drug Administration will ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. AbbVie on Monday said it would buy ...

A new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.

A new study found that two diversity-oriented programs supported by the NIH doubled the odds that an undergraduate would earn ...